Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.
The EMBO Journal|November 5, 2015
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugsRosa Planells-Cases, Darius Lutter, Charlotte Guyader, et al.
Molecular Cell|January 18, 2016
HELB Is a Feedback Inhibitor of DNA End ResectionJán Tkáč, Guotai Xu, Hemanta Adhikary, et al.
British Journal of Cancer|June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer riskMathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Nature|February 24, 2022
Effective drug combinations in breast, colon and pancreatic cancer cellsPatricia Jaaks, Elizabeth A Coker, Daniel J Vis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patientsTesa M Severson, Yanyun Zhu, Stefan Prekovic, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
Cell|December 12, 2017
A Living Biobank of Breast Cancer Organoids Captures Disease HeterogeneityNorman Sachs, Joep de Ligt, Oded Kopper, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Pageof 14